Basilea Pharmaceutica AG (BPMUF)
OTCMKTS · Delayed Price · Currency is USD
71.00
-0.60 (-0.84%)
At close: Jan 30, 2026
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of $928.32 million as of February 12, 2026. Its market cap has increased by 76.10% in one year.
Market Cap
928.32M
Enterprise Value
887.26M
Revenue
297.01M
Ranking
n/a
PE Ratio
10.16
Stock Price
$71.00
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 418.27M to 928.32M, an increase of 121.94%. That is a compound annual growth rate of 3.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 922.35M | 8.49% |
| Dec 30, 2025 | 850.17M | 53.85% |
| Dec 30, 2024 | 552.59M | 10.03% |
| Dec 29, 2023 | 502.22M | -14.92% |
| Dec 30, 2022 | 590.31M | 11.34% |
| Dec 30, 2021 | 530.19M | -18.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 411.40M |
| CytoDyn | 305.90M |
| Silence Therapeutics | 204.52M |
| HST Global | 139.70M |
| Vaxart | 137.92M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 72.43M |
| VitaSpring Biomedical | 51.78M |